Comparing two methods of treatment for arm pit sweating
Not Applicable
- Conditions
- Health Condition 1: null- Axillary hyperhidrosis
- Registration Number
- CTRI/2015/06/005935
- Lead Sponsor
- Indian Academy of Dermatology Venereology and Leprosy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
•18 to 75 years
•Persistent bilateral primary axillary hyperhidrosis
•Gravimetrically minimal 50 mg spontaneous sweat production in each axilla, measured during 5 minutes in room temperature in calm condition
•signed informed consent
Exclusion Criteria
•Medical condition that can be dangerous by treatment with Botulinum toxin, including myastenia gravis, Lambert-Eaton syndrome and each other disease that can interfere with the neuromuscular function
•Secondary hyperhidrosis
•Known allergy against study medication
•Use of aminoglycosides, curare-like products, or other products which can interfere with the neuromuscular function
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effectiviness based on reduction in sweat production measured by gravimetry and duration of effect of both treatmentsTimepoint: Follow up assessments: 3 months, 6 months and 12 months
- Secondary Outcome Measures
Name Time Method Subject satisfaction based on reduction in mean score on the Hyperhidrosis Disease Severity Scale (HDSS). <br/ ><br> Adverse events of both treatments <br/ ><br>Timepoint: Follow up assessments: 3 months, 6 months and 12 months